Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma × Gels × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Condylomata Acuminata 3 Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Keratosis, Actinic 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Wounds and Injuries 1 Virus Diseases 1 Usual Type Vulval Intraepithelial Neoplasia (uVIN) 1 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Sexually Transmitted Diseases 1 Parapsoriasis 1 Papillomavirus Infections 1 Non-Muscle Invasive Bladder Neoplasms 1 Non-Melanoma Skin Cancers 1 Lymphoma, Follicular 1 Keratosis, Seborrheic 1 Hypogonadism 1 Hemangioma, Cavernous 1 Hemangioma 1 Fatigue 1 Exanthema 1 Eunuchism 1 Dermatitis, Contact 1

Interventions

Cisplatin 24 Paclitaxel 18 Carboplatin 18 Gemcitabine 12 pembrolizumab 11 Radiotherapy 9 Fluorouracil 9 Specimen Handling 8 Magnetic Resonance Spectroscopy 7 cemiplimab 6 Platinum 6 Nivolumab 6 Docetaxel 6 Cetuximab 6 1,2-diaminocyclohexaneplatinum II citrate 6 epothilone B 5 anlotinib 5 Sunitinib 5 Pemetrexed 5 Oxaliplatin 5 Everolimus 5 Drug Therapy 5 Cyclophosphamide 5 Capecitabine 5 Bevacizumab 5 durvalumab 4 Radiotherapy, Intensity-Modulated 4 Radiation 4 vosaroxin 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03546166 2023-07-21

PICABAS

Centre Hospitalier Universitaire de Nice

Phase 2 Completed

Carcinoma, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡